Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Grove

Craig Nicholas Grove, Dudley GB

Patent application numberDescriptionPublished
20090116665Compressing the Level of an Audio Signal - An audio signal in which an audio signal is received as a stream of digital samples, each being a numerical value representing a sampled signal level. A first zero crossing point is identified and the received audio samples are stored until a second zero crossing point is identified, thereby storing a first half-wave of samples. The highest intensity sample is identified from the stored samples and this is compared against a predetermined threshold. All stored samples are scaled by an initial scaling factor so that the intensity of the highest intensity sample is not above this threshold. A second half-wave of samples is stored in which all samples of the second half-wave are below the threshold. All stored samples of the second half-wave are also scaled but by a modified scaling factor derived from a combination of the initial scaling factor and a decay factor.05-07-2009

Philip Grove, West Midlands GB

Patent application numberDescriptionPublished
20100132152WET TYPE SUCTION CLEANERS - A wet type suction cleaner comprising a tank (06-03-2010

Simon James Anthony Grove, Newhouse GB

Patent application numberDescriptionPublished
20080262221(PYRIDO/THIENO)-[f]-OXAZEPINE-5-ONE DERIVATIVES - The present invention relates to (pyrido/thieno)-[f]-oxazepine-5-one derivatives having the general Formula I10-23-2008
20090163473(PYRIDO/THIENO)-[f]-OXAZEPINE-5-ONE DERIVATIVES - The present invention relates to (pyrido/thieno)-[f]-oxazepine-5-one derivatives having the general Formula I06-25-2009
20100113493(PYRROLIDIN-2-YL)PHENYL DERIVATIVES - The invention relates to (pyrrolidin-2-yl)phenyl derivatives having the general Formula I05-06-2010
20100210680TRICYCLIC HETEROCYCLIC DERIVATIVES - The present invention relates to a tricyclic heterocyclic derivative of Formula (I) wherein the variables are as defined in the specification. The present invention further relates to pharmaceutical compositions comprising these compounds and to their use in therapy, in particular for the treatment of serotonin-mediated disorders such as obesity, schizophrenia and cognitive dysfunction.08-19-2010

Patent applications by Simon James Anthony Grove, Newhouse GB